US biotech Iovance Biotherapeutics is cutting 19% of its workforce due to slower-than-expected launch of its ...

India’s pharmaceutical sector continues to assert its dominance on the global stage, driven by a surge in generic drug launches that are reshaping access to affordable healthcare. A flurry of filings ...

Shares in Gilead Sciences were a massive 9% higher in Friday’s early trading after the US biotech major lifted its full-year financial guidance.

US pharma major AbbVie recently announced top-line results from one of two parallel studies of the pivotal Phase III UP-AA ...

The cancer immunotherapy market is bracing for its next growth phase as bispecific T-cell engagers gain momentum, according ...

German family-owned pharma major Boehringer Ingelheim and New York-based Click Therapeutics today announced that the pivotal ...

UK pharma major GSK (LSE: GSK) today announced that, in connection with the mRNA patent settlement reached between CureVac ...

French vaccines developer Valneva announced that the US Food and Drug Administration (FDA) has removed its recommended pause ...

A Californian company developing new treatments to help organ transplant patients keep their transplanted organs healthy over the long term.

US clinical-stage biotech Keros Therapeutics has announced a strategic realignment designed to reallocate resources towards ...

Danish biotech Genmab (Nasdaq: GMAB) posted second-quarter revenue of $925 million, up 19% from a year earlier, driven by ...

Drug-resistant infections now claim more lives each year than HIV/AIDS or malaria, and the toll is rising. The World Health Organization warns that without urgent action, antimicrobial resistance (AMR ...